Temsamani Karim Saad 4
4 · Cardlytics, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Temsamani Karim Saad
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-01-01+50,000→ 308,858 total - Exercise/Conversion
Restricted Stock Unit
2024-01-01−50,000→ 50,000 total→ Common Stock (50,000 underlying) - Sale
Common Stock
2024-01-03$7.77/sh−31,123$241,826→ 277,735 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
- [F2]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on January 1, 2024.
- [F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.50 to $8.3825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
- [F4]This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024. An additional 25% of the RSU award shall vest on April 1, 2024 subject to the Reporting Person's continuous service with the Issuer through the vesting date.